ESTRO 2022 - Abstract Book

S516

Abstract book

ESTRO 2022

common PROMs format observed was completion of paper forms by patients. PROMs data were most commonly used to assess patients or obtained as part of a clinical trial. Key themes relating to the barriers and facilitators of PROMs use were derived from thematic analysis of free-text comments (figure 2).

Conclusion It is clear that PROMs are not widely used within RT practice. Here, we provide recommendations to mitigate the barriers identified and implement PROMs in RT. These include HCP training on the appropriate use and value of PROMs and development/integration of electronic systems. Standardisation of PROMs tools and storage of data in a central repository would provide effective means of capturing RT toxicity data nationally, informing future practice. In order to utilise PROMs results effectively to improve patient QOL, referral pathways to existing specialist services must first be established. This study provides a vital first step in driving the implementation of PROMs within UK RT services.

OC-0591 Defining the psychiatric burden of mental and substance use disorders in cancer patients

S. Baliga 1 , B. Klamer 1 , J. Palmer 1 , S. Wells-Di Gregirio 2 , S. Kale 1 , M. Bonomi 3 , M. Old 4 , J. Rocco 4 , D. Blakaj 1

1 The Ohio State University Wexner Medical Center, Radiation Oncology, Dublin, USA; 2 The Ohio State University Wexner Medical Center, Psychiatry and Behavioral Health, Dublin, USA; 3 The Ohio State University Wexner Medical Center, Medical Oncology, Dublin, USA; 4 The Ohio State University Wexner Medical Center, Otolaryngology, Dublin, USA Purpose or Objective To identify the proportion of Emergency Department (ED) visits in cancer patients associated with a Mental/Substance Use Disorder (MSUD) and the subsequent healthcare costs. Materials and Methods Nationally representative data on ED visits from 2009-2018 was obtained from the Nationwide Emergency Department Sample (NEDS). We identified cancer related visits with or without a MSUD using the Clinical Classifications Software diagnoses documented during the ED visit. Survey adjusted frequencies and proportions of ED visits among adult cancer patients with or without a MSUD was evaluated. Survey adjusted multivariable logistic regression models were used to examine demographic and clinical predictors of the presence of an MSUD and the likelihood of admission for patients with a primary MSUD. Results Among 50,810,552 ED visits with a cancer diagnosis between 2009-2018, 10,896,241 (21%) were associated with a MSUD. Cancer patients with an associated MSUD diagnosis were more likely to be female (54% versus 49.4%), younger (median: 58 versus 66), more likely to have Medicaid insurance (14% versus 9.4%), and more likely to be admitted as an inpatient (65% versus 49%). Of the 951,477 visits associated with a chief complaint of an MSUD, 5,779 resulted in death either in the